Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ONPATTRO
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ONPATTRO

Medicine - Posted on Jan 22 2020 - Updated on Jan 22 2020
Active substance (DCI)
  • patisiran
history (2)
  • 1/8/20

    ONPATTRO (patisiran)

    Mise à disposition en ville L’essentiel Avis favorable au remboursement en ville dans le traitement de l’amylose héréditaire...
    CAV :
    54321
    icône flèche
  • Economic analysis
    3/20/19

    ONPATTRO (patisiran)

    Intérêt clinique important dans le traitement de l’amylose héréditaire à transthyrétine chez les adultes atteints de polyneu...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • N07XX12
Manufacturer
ALNYLAM FRANCE
Presentation

ONPATTRO 2 mg/ml, solution à diluer pour perfusion (code CIS : 62111751)
1 flacon(s) en verre de 5 ml - Code CIP : 34009 301 584 2 5

All our publications
    Congenital, genetic and rare diseases Drug therapy Endocrine system and metabolic diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PU07BuX9Qzt4VKeW